Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I, Randomized, Controlled, Third-party Double-blind, Dose Escalating Study of Protexia Administered Intramuscularly at One or Two Time Points in Healthy Human Volunteers

NCT00744146 is registered in ClinicalTrials.gov with PharmAthene, Inc. as lead sponsor.

NCT NCT00744146
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00744146 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I, Randomized, Controlled, Third-party Double-blind, Dose Escalating Study of Protexia Administered Intramuscularly at One or Two Time Points in Healthy Human Volunteers
Lead sponsor
PharmAthene, Inc.
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2008
Completion date
November 30, 2009
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intervention for nerve agent exposure